Intra-Cellular Therapies Inc. Stock Forecast
Intra-Cellular Therapies Inc. stock downgraded to Sell Candidate
(Updated on May 03, 2024)
The Intra-Cellular Therapies Inc. stock price fell by -2.19% on the last day (Friday, 3rd May 2024) from $70.34 to $68.80. During the last trading day the stock fluctuated 4.19% from a day low at $68.48 to a day high of $71.35. The price has fallen in 7 of the last 10 days and is down by -4.93% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -313 thousand shares and in total, 893 thousand shares were bought and sold for approximately $61.43 million.
The stock is moving within a wide and horizontal trend and further movements within this trend can be expected. Given the current horizontal trend, you can expect Intra-Cellular Therapies Inc. stock with a 90% probability to be traded between $65.04 and $80.42 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
ITCI Signals & Forecast
There are few to no technical positive signals at the moment. The Intra-Cellular Therapies Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at $71.62 and $69.67. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Tuesday, April 16, 2024, and so far it has fallen -13.83%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements. The stock had a Golden Star Signal on Friday, April 05, 2024 in the short-term chart.
Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the stock in question.
Golden Star
The stock had a Golden Star Signal on Friday, April 05, 2024 in the short-term chart.Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the stock in question.
Support, Risk & Stop-loss for Intra-Cellular Therapies Inc. stock
Intra-Cellular Therapies Inc. finds support from accumulated volume at $68.57 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $2.87 between high and low, or 4.19%. For the last week, the stock has had daily average volatility of 3.41%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (ITCI) For The Upcoming Trading Day Of Monday 6th
For the upcoming trading day on Monday, 6th we expect Intra-Cellular Therapies Inc. to open at $69.54, and during the day (based on 14 day Average True Range), to move between $65.72 and $71.88, which gives a possible trading interval of +/-$3.08 (+/-4.48%) up or down from last closing price. If Intra-Cellular Therapies Inc. takes out the full calculated possible swing range there will be an estimated 8.96% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $68.57 (0.33%) than the resistance at $72.00 (4.65%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is Intra-Cellular Therapies Inc. stock A Buy?
Intra-Cellular Therapies Inc. holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.
Current score: -3.214 Sell Candidate Downgraded
Predicted Opening Price for Intra-Cellular Therapies Inc. of Monday, May 6, 2024
| Fair opening price May 6, 2024 | Current price |
|---|---|
| $69.54 ( 1.08%) | $68.80 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for ITCI
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 72.41 | 5.25 % | |
| R2 | 71.32 | 3.66 % | ||
| R1 | 70.64 | 2.67 % | ||
| Current price: | 68.80 | |||
| Support | S1 | 68.45 | -0.513 % | |
| S2 | 67.77 | -1.50 % | ||
| S3 | 66.67 | -3.09 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 79.84 | 16.05 % | |
| R2 | 76.69 | 11.47 % | ||
| R1 | 72.00 | 4.65 % | ||
| Current price | 68.80 | |||
| Support | S1 | 68.57 | -0.334% | |
| S2 | 67.97 | -1.21% | ||
| S3 | 67.21 | -2.31% |
FAQ
Click here for our free guide on how to buy Intra-Cellular Therapies Inc. Stock.
